Suchergebnisse - "Cervantes, A"

PubPharm (22)

1

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO) : a randomised, open-label, phase 3 trial

enthalten in: The Lancet. Oncology | 2021

von Bahadoer, R. | Dijkstra, E. | van Etten, B. | +118

CommentIn: Lancet Oncol. 2021 Jan;22(1):2-3. - PMID 33301739

2

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370) : a multicentre, open-label, phase 3, randomised, controlled trial

enthalten in: The Lancet. Oncology | 2019

von Eng, C. | Kim, T. | Bendell, J. | +77

CommentIn: Lancet Oncol. 2019 Jun;20(6):752-753. - PMID 31003912

3

Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer

enthalten in: Scientific reports | 2019

von Borrero-Palacios, A. | Cebrián, A. | Gómez Del Pulgar, M. | +21

ErratumIn: Sci Rep. 2019 May 17;9(1):7706. - PMID 31097738

4

Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain : results of a subgroup analysis of the phase 3 RECOURSE trial

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2017

von Longo-Muñoz, F. | Argiles, G. | Tabernero, J. | +8

5

Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer : results of the EXPERT-C trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Sclafani, F. | Chau, I. | Cunningham, D. | +16

6

Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer

enthalten in: British journal of cancer | 2015

von Macarulla, T. | Cervantes, A. | Tabernero, J. | +10

7

Achievement of therapeutic targets in Mexican patients with diabetes mellitus

enthalten in: Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion | 2012

von Lavalle-González, F. | Chiquete, E. | de la Luz, J. | +104

8

Cetuximab administered once every second week to patients with metastatic colorectal cancer : a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2010

von Tabernero, J. | Ciardiello, F. | Rivera, F. | +10

9

FOLFOX in patients with metastatic colorectal cancer and high alkaline phosphatase level : an exploratory cohort of the GERCOR OPTIMOX1 study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2009

von Chibaudel, B. | Tournigand, C. | Artru, P. | +12

10

A phase IIA study of the topoisomerase I inhibitor, exatecan mesylate (DX-8951f), administered at two different dose schedules in patients with platinum- and taxane-resistant/refractory ovarian cancer

enthalten in: Gynecologic oncology | 2004

von Clamp, A. | Adams, M. | Atkinson, R. | +8